|
IL105554A
(en)
*
|
1992-05-05 |
1999-08-17 |
Univ Leiden |
Peptides of human papillomavirus for use in preparations elicit a human T cell response
|
|
US20050100928A1
(en)
*
|
1999-09-16 |
2005-05-12 |
Zycos Inc., A Delaware Corporation |
Nucleic acids encoding polyepitope polypeptides
|
|
CA2509197A1
(en)
*
|
2002-12-06 |
2004-06-24 |
The United States Of America As Represented By The Secretary Of The Navy |
Plasmodium falciparum antigens and methods of use
|
|
AU2005222776A1
(en)
*
|
2003-12-31 |
2005-09-29 |
Genimmune N.V. |
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
|
|
GB0716992D0
(en)
|
2007-08-31 |
2007-10-10 |
Immune Targeting Systems Its L |
Influenza antigen delivery vectors and constructs
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
CN101378772B
(zh)
|
2005-08-05 |
2013-12-04 |
阿拉伊姆药品公司 |
组织保护性肽及其用途
|
|
DE102005041616B4
(de)
*
|
2005-09-01 |
2011-03-17 |
Johannes-Gutenberg-Universität Mainz |
Melanom-assoziierte MHC Klasse I assoziierte Oligopeptide und für diese kodierende Polynukleotide und deren Verwendungen
|
|
RU2507213C2
(ru)
|
2005-10-04 |
2014-02-20 |
Солидженикс, Инк., |
Новые пептиды для лечения и профилактики иммунопатологических заболеваний, включая лечение и профилактику инфекции посредством модулирования врожденного иммунитета
|
|
KR20080106467A
(ko)
|
2006-03-10 |
2008-12-05 |
펩트셀 리미티드 |
Ｈｉｖ 조절 또는 보조 단백질의 펩타이드, 그 조성물 및 이용 방법
|
|
US8361479B2
(en)
*
|
2006-08-11 |
2013-01-29 |
Dendreon Corporation |
Promiscuous PAP CD4 T cell epitopes
|
|
US8097256B2
(en)
|
2006-09-28 |
2012-01-17 |
Cedars-Sinai Medical Center |
Cancer vaccines and vaccination methods
|
|
WO2008086813A2
(en)
*
|
2007-01-19 |
2008-07-24 |
Kobenhavns Universitet |
Peptides derived from proteins of the insulin super-family
|
|
US8742067B2
(en)
*
|
2007-05-16 |
2014-06-03 |
Gene Signal International Sa |
Anti-tumor drug, medicament, composition, and use thereof
|
|
WO2009033769A2
(en)
*
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of cortistatin 14 and others as a therapeutic agent
|
|
EP2187953A2
(en)
*
|
2007-09-11 |
2010-05-26 |
Mondobiotech Laboratories AG |
Use of a peptide as a therapeutic agent
|
|
US20090117140A1
(en)
*
|
2007-09-26 |
2009-05-07 |
Mayumi Nakagawa |
Human papilloma virus dominant CD4 T cell epitopes and uses thereof
|
|
WO2009046739A1
(en)
*
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating prostate cancer (pca)
|
|
GB0722105D0
(en)
*
|
2007-11-10 |
2007-12-19 |
Sec Dep For Environment Food A |
Antigens
|
|
WO2009093251A2
(en)
*
|
2008-01-24 |
2009-07-30 |
Gavish-Galilee Bio Applications Ltd |
Reovirus vaccine based on sigma c protein sequence
|
|
KR20090125629A
(ko)
*
|
2008-06-02 |
2009-12-07 |
바이오코아 주식회사 |
면역성 펩타이드 및 그 펩타이드를 포함하는 ｈｐｖ 관련질환 예방 또는 치료용 조성물
|
|
FR2940291B1
(fr)
*
|
2008-12-23 |
2012-12-21 |
Isp Investments Inc |
Peptide derive d'hmg-coa reductase et composition cosmetique ou pharmaceutique le contenant
|
|
FR2940125B1
(fr)
*
|
2008-12-23 |
2013-03-22 |
Isp Investments Inc |
Composition cosmetique ou pharmaceutique apaisante comprenant un peptide activateur de la hmg-coa reductase
|
|
US9249187B2
(en)
|
2009-01-28 |
2016-02-02 |
Epimmune Inc. |
Pan-DR binding polypeptides and uses thereof
|
|
FR2944526B1
(fr)
|
2009-04-15 |
2013-05-10 |
Isp Investments Inc |
Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique capable de renforcer la fonction barriere
|
|
FR2944445B1
(fr)
|
2009-04-15 |
2013-08-16 |
Isp Investments Inc |
Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat peptidique apaisant
|
|
US8933036B2
(en)
|
2009-04-15 |
2015-01-13 |
Isp Investments Inc. |
Cosmetic and/or pharmaceutical composition comprising a yeast peptide hydrolysate and use of the yeast peptide hydrolysate as an active agent for strengthening hair
|
|
DK2556171T3
(en)
|
2010-04-05 |
2015-12-14 |
Prognosys Biosciences Inc |
Spatially CODED BIOLOGICAL ASSAYS
|
|
US20190300945A1
(en)
|
2010-04-05 |
2019-10-03 |
Prognosys Biosciences, Inc. |
Spatially Encoded Biological Assays
|
|
US10787701B2
(en)
|
2010-04-05 |
2020-09-29 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays
|
|
WO2012046238A2
(en)
*
|
2010-10-06 |
2012-04-12 |
Ramot At Tel-Aviv University Ltd. |
Erythropoietin receptor antagonists
|
|
US20120258871A1
(en)
|
2011-04-08 |
2012-10-11 |
Prognosys Biosciences, Inc. |
Peptide constructs and assay systems
|
|
GB201106254D0
(en)
|
2011-04-13 |
2011-05-25 |
Frisen Jonas |
Method and product
|
|
JP2011239787A
(ja)
*
|
2011-08-15 |
2011-12-01 |
Igaku Seibutsugaku Kenkyusho:Kk |
エプスタイン−バールウイルス感染細胞を特異的に攻撃する細胞傷害性ｔ細胞エピトープペプチド及びその用途
|
|
WO2014060483A1
(en)
|
2012-10-17 |
2014-04-24 |
Spatial Transcriptomics Ab |
Methods and product for optimising localised or spatial detection of gene expression in a tissue sample
|
|
WO2014127296A1
(en)
|
2013-02-14 |
2014-08-21 |
Immunocellular Therapeutics, Ltd |
Cancer vaccines and vaccination methods
|
|
WO2014145047A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Prognosys Biosciences, Inc. |
Methods for detecting peptide/mhc/tcr binding
|
|
US9868979B2
(en)
|
2013-06-25 |
2018-01-16 |
Prognosys Biosciences, Inc. |
Spatially encoded biological assays using a microfluidic device
|
|
EP2883550A1
(en)
*
|
2013-12-12 |
2015-06-17 |
Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts |
Novel promiscuous HPV16-derived T helper epitopes for immunotherapy
|
|
EP4282977B1
(en)
|
2015-04-10 |
2024-06-05 |
10x Genomics Sweden AB |
Spatially distinguished, multiplex nucleic acid analysis of biological specimens
|
|
GB201513921D0
(en)
|
2015-08-05 |
2015-09-23 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
|
|
WO2018065625A2
(en)
|
2016-10-07 |
2018-04-12 |
Enterome |
Immunogenic compounds for cancer therapy
|
|
CN110049774A
(zh)
|
2016-10-07 |
2019-07-23 |
恩特罗姆公司 |
肿瘤相关抗原表位的小型生物群序列变体
|
|
IL302345B2
(en)
|
2016-10-07 |
2024-12-01 |
Enterome S A |
Immunogenic compounds for cancer therapy
|
|
BR112019013402A2
(pt)
|
2016-12-28 |
2020-03-03 |
Invvax, Inc. |
Vacinas de influenza
|
|
EP3545967A1
(en)
*
|
2018-03-28 |
2019-10-02 |
Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts |
Cancer immunization platform
|
|
SI3773689T1
(sl)
|
2018-04-11 |
2023-02-28 |
Enterome S.A. |
Antigenski peptidi za preprečevanje in zdravljenje raka
|
|
SG11202101858RA
(en)
*
|
2018-08-31 |
2021-03-30 |
3T Biosciences Inc |
Randomized peptide libraries presented by human leukocyte antigens
|
|
CN110240644B
(zh)
*
|
2019-06-28 |
2021-03-16 |
深圳市亚辉龙生物科技股份有限公司 |
人生长激素受体突变体、人生长激素免疫原、多克隆抗体及检测试剂盒
|
|
AU2020398147A1
(en)
|
2019-12-06 |
2022-06-02 |
Dr. Mary Morris & Associates, Llc |
Methods and compositions for the treatment and prevention of Type 1 diabetes
|
|
CN111704651B
(zh)
*
|
2020-07-27 |
2021-10-08 |
南京安吉生物科技有限公司 |
具有抗衰老作用的多肽rv3和rv4及其应用
|
|
CN112898401A
(zh)
*
|
2021-02-05 |
2021-06-04 |
合肥瑞城生生物科技有限公司 |
一种钙网蛋白组合肽及其用途
|
|
JP2026507123A
(ja)
|
2023-02-28 |
2026-02-27 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
Ｔ細胞活性化剤およびその使用方法
|